Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 3 | $10,100,948 |
Sells | 22 | $4,347,702 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
03 May 2023 18:26 | EWTX | Edgewise Therapeutics Inc | CARRUTHERS R MICHAEL | Chief Financial Officer | 02 May 2023 | Sale | 1,336 | 8.9049 | 11,897 | D |
09 Feb 2024 17:42 | EWTX | Edgewise Therapeutics Inc | DERAKHSHAN BEHRAD | Chief Business Officer | 07 Feb 2024 | Sale | 600 | 20 | 12,000 | D |
03 May 2023 18:26 | EWTX | Edgewise Therapeutics Inc | RUSSELL ALAN J | Chief Scientific Officer | 02 May 2023 | Sale | 1,602 | 8.9049 | 14,266 | D |
03 May 2023 18:26 | EWTX | Edgewise Therapeutics Inc | DERAKHSHAN BEHRAD | Chief Business Officer | 02 May 2023 | Sale | 1,747 | 8.9049 | 15,557 | D |
03 May 2023 18:26 | EWTX | Edgewise Therapeutics Inc | MOORE JOHN R | General Counsel | 02 May 2023 | Sale | 1,897 | 8.9049 | 16,893 | D |
03 May 2023 18:25 | EWTX | Edgewise Therapeutics Inc | KOCH KEVIN | President and CEO | 02 May 2023 | Sale | 3,203 | 8.9049 | 28,522 | D |
03 May 2023 18:25 | EWTX | Edgewise Therapeutics Inc | DONOVAN JOANNE M. | CMO | 02 May 2023 | Sale | 3,254 | 8.9049 | 28,977 | D |
03 May 2024 18:28 | EWTX | Edgewise Therapeutics Inc | RUSSELL ALAN J | Chief Scientific Officer | 02 May 2024 | Sale | 1,576 | 18.91 | 29,802 | D |
03 May 2024 18:29 | EWTX | Edgewise Therapeutics Inc | DERAKHSHAN BEHRAD | Chief Business Officer | 02 May 2024 | Sale | 1,718 | 18.91 | 32,487 | D |
03 May 2024 18:31 | EWTX | Edgewise Therapeutics Inc | MOORE JOHN R | General Counsel | 02 May 2024 | Sale | 1,956 | 18.91 | 36,988 | D |
03 May 2024 18:30 | EWTX | Edgewise Therapeutics Inc | CARRUTHERS R MICHAEL | Chief Financial Officer | 02 May 2024 | Sale | 2,157 | 18.91 | 40,789 | D |
05 Oct 2022 16:42 | EWTX | Edgewise Therapeutics Inc | MOORE JOHN R | General Counsel | 03 Oct 2022 | Sale | 4,730 | 9.7579 | 46,155 | D |
03 May 2024 18:26 | EWTX | Edgewise Therapeutics Inc | KOCH KEVIN | President and CEO | 02 May 2024 | Sale | 3,152 | 18.91 | 59,604 | D |
03 May 2024 18:27 | EWTX | Edgewise Therapeutics Inc | DONOVAN JOANNE M. | CMO | 02 May 2024 | Sale | 3,682 | 18.91 | 69,627 | D |
09 Feb 2024 17:43 | EWTX | Edgewise Therapeutics Inc | MOORE JOHN R | General Counsel | 08 Feb 2024 | Sale | 3,813 | 20.0065 | 76,285 | D |
28 Dec 2023 16:39 | EWTX | Edgewise Therapeutics Inc | MOORE JOHN R | General Counsel | 27 Dec 2023 | Sale | 8,497 | 10.5 | 89,218 | D |
09 Feb 2024 17:42 | EWTX | Edgewise Therapeutics Inc | DERAKHSHAN BEHRAD | Chief Business Officer | 08 Feb 2024 | Sale | 4,600 | 20.0106 | 92,049 | D |
09 Feb 2024 17:42 | EWTX | Edgewise Therapeutics Inc | DERAKHSHAN BEHRAD | Chief Business Officer | 09 Feb 2024 | Sale | 4,800 | 20.0436 | 96,209 | D |
28 Dec 2023 16:39 | EWTX | Edgewise Therapeutics Inc | FOX JONATHAN C | Director | 26 Dec 2023 | Purchase | 10,857 | 9.2989 | 100,958 | D |
09 Feb 2024 17:43 | EWTX | Edgewise Therapeutics Inc | MOORE JOHN R | General Counsel | 09 Feb 2024 | Sale | 8,029 | 20.0096 | 160,657 | D |
09 Feb 2024 17:43 | EWTX | Edgewise Therapeutics Inc | MOORE JOHN R | General Counsel | 07 Feb 2024 | Sale | 17,993 | 20.0002 | 359,864 | D |
25 Jan 2024 16:46 | EWTX | Edgewise Therapeutics Inc | CARRUTHERS R MICHAEL | Chief Financial Officer | 23 Jan 2024 | Sale | 90,000 | 15.7751 | 1,419,759 | D |
28 Dec 2023 16:38 | EWTX | Edgewise Therapeutics Inc | RUSSELL ALAN J | Chief Scientific Officer | 26 Dec 2023 | Sale | 172,585 | 9.3293 | 1,610,097 | D |
25 Jan 2024 16:32 | EWTX | Edgewise Therapeutics Inc | THOMPSON PETER A. | Director , 10% | 23 Jan 2024 | Purchase | 454,545 | 11 | 4,999,995 | I |
25 Jan 2024 16:28 | EWTX | Edgewise Therapeutics Inc | ORBIMED ADVISORS LLC | Director , 10% | 23 Jan 2024 | Purchase | 454,545 | 11 | 4,999,995 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)